Get Live Data

Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Total Voting Rights

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

2 Jul 2018 14:30

RNS Number : 2896T
GlaxoSmithKline PLC
02 July 2018
 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 30 June 2018 consisted of 5,374,473,060 shares of 25 pence each ('Ordinary Shares'), of which 414,605,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,959,867,110. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

 

V A Whyte

Company Secretary

 

2 July 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRUGUWGMUPRGWP
141516171819202122
Date   Source Headline
15th Jan 20193:01 pmRNSDirector/PDMR Shareholding
15th Jan 20192:59 pmRNSDirector/PDMR Shareholding
15th Jan 20192:56 pmRNSDirector/PDMR Shareholding
15th Jan 20192:47 pmRNSDirector/PDMR Shareholding
15th Jan 201912:00 pmRNSGlaxoSmithKline Extends Tender Offer for TESARO
11th Jan 20194:32 pmRNSDirector/PDMR Shareholding
11th Jan 20194:25 pmRNSDirector/PDMR Shareholding
2nd Jan 20191:45 pmRNSTotal Voting Rights
20th Dec 20185:15 pmRNSDirector/PDMR Shareholding
19th Dec 20187:00 amRNSGSK and Pfizer create new Consumer Healthcare JV
14th Dec 20181:20 pmRNSGSK Commences Tender Offer for TESARO Inc.
12th Dec 20184:35 pmRNSDirector/PDMR Shareholding
4th Dec 201810:07 amRNSDirector/PDMR Shareholding
3rd Dec 20182:00 pmRNSTotal Voting Rights
3rd Dec 201812:02 pmRNSGSK reaches agreement to acquire TESARO
3rd Dec 20188:35 amRNSGSK to divest Horlicks to Unilever
30th Nov 20184:40 pmRNSSecond Price Monitoring Extn
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20183:40 pmRNSDirector/PDMR Shareholding
29th Nov 201811:45 amRNSGSK - Update on Review of Horlicks
27th Nov 20183:25 pmRNSBlock listing Interim Review
22nd Nov 20181:02 pmRNSGSK publishes 2019 Dividend Dates
12th Nov 20182:45 pmRNSDirector/PDMR Shareholding
12th Nov 20189:00 amRNSBlocklisting Application
8th Nov 201812:43 pmRNSDirector Declaration
2nd Nov 20184:15 pmRNSDirector/PDMR Shareholding
1st Nov 20181:40 pmRNSTotal Voting Rights
31st Oct 20182:15 pmRNSViiV positive phIII results with fostemsavir
31st Oct 201812:07 pmRNSSecond Price Monitoring Extn
31st Oct 201812:02 pmRNSPrice Monitoring Extension
31st Oct 201812:00 pmRNS3rd Quarter Results
30th Oct 20182:30 pmRNSViiV: positive data for long-acting injectable
29th Oct 201810:00 amRNSViiV - three-year data for long-acting injectable
18th Oct 20184:00 pmRNSViiV submits HIV 2DR regulatory application to FDA
18th Oct 20189:34 amRNSDirector/PDMR Shareholding
17th Oct 20185:56 pmRNSDirector/PDMR Shareholding
17th Oct 20185:50 pmRNSDirector/PDMR Shareholding
17th Oct 201811:30 amRNSDirector/PDMR Shareholding
16th Oct 20184:53 pmRNSDirector/PDMR Shareholding
16th Oct 20189:30 amRNSDirector/PDMR Shareholding
16th Oct 20189:30 amRNSDirector/PDMR Shareholding
10th Oct 20183:30 pmRNSDirector/PDMR Shareholding
1st Oct 20181:58 pmRNSTotal Voting Rights
27th Sep 20184:35 pmRNSDirector/PDMR Shareholding
21st Sep 201812:30 pmRNSCHMP recommends expansion of Trelegy COPD label
14th Sep 20189:00 amRNSViiV submits HIV 2DR regulatory application to EMA
12th Sep 20185:43 pmRNSDirector/PDMR Shareholding
10th Sep 20188:00 amRNSNew analysis on efficacy of anti-IL5 biologics SEA
10th Sep 20187:00 amRNSGSK receives CRL from FDA for mepolizumab in COPD
7th Sep 20182:24 pmRNSDirector/PDMR Shareholding
141516171819202122

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.